Healthcare provider profile · identity verified

Derris Wayne Ray, M.D.

Family Practice · AMITE, LA · NPI 1780679746

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pantoprazole Sodium	Pantoprazole Sodium	448	110
Alprazolam	Alprazolam	380	65
Levothyroxine Sodium	Levothyroxine Sodium	374	93
Atorvastatin Calcium	Atorvastatin Calcium	358	90
Gabapentin	Gabapentin	339	83
Amlodipine Besylate	Amlodipine Besylate	319	81
Dexamethasone	Dexamethasone	287	185
Metoprolol Succinate	Metoprolol Succinate	281	67
Metformin Hcl	Metformin Hcl	271	79
Rosuvastatin Calcium	Rosuvastatin Calcium	249	62
Furosemide	Furosemide	247	77
Trazodone Hcl	Trazodone Hcl	234	51
Ondansetron Odt	Ondansetron	200	42
Tramadol Hcl	Tramadol Hcl	194	28
Meloxicam	Meloxicam	187	49
Albuterol Sulfate Hfa	Albuterol Sulfate	169	44
Lisinopril	Lisinopril	167	47
Prednisone	Prednisone	158	94
Tizanidine Hcl	Tizanidine Hcl	156	46
Pravastatin Sodium	Pravastatin Sodium	151	37
Montelukast Sodium	Montelukast Sodium	146	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	140	44
Allopurinol	Allopurinol	139	34
Potassium Chloride	Potassium Chloride	137	33
Losartan Potassium	Losartan Potassium	129	40
Tamsulosin Hcl	Tamsulosin Hcl	125	30
Omeprazole	Omeprazole	123	31
Famotidine	Famotidine	115	23
Glimepiride	Glimepiride	103	28
Carvedilol	Carvedilol	102	18
Duloxetine Hcl	Duloxetine Hcl	99	23
Doxycycline Hyclate	Doxycycline Hyclate	96	66
Ezetimibe	Ezetimibe	95	30
Ozempic	Semaglutide	95	20
Clopidogrel	Clopidogrel Bisulfate	94	29
Fluticasone Propionate	Fluticasone Propionate	94	32
Eliquis	Apixaban	93	17
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	89	21
Ropinirole Hcl	Ropinirole Hcl	89	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	88	73
Azithromycin	Azithromycin	82	61
Cefdinir	Cefdinir	82	70
Sertraline Hcl	Sertraline Hcl	79	22
Mupirocin	Mupirocin	78	50
Escitalopram Oxalate	Escitalopram Oxalate	73	14
Citalopram Hbr	Citalopram Hydrobromide	72	17
Ibuprofen	Ibuprofen	72	22
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	69	16
Mounjaro	Tirzepatide	67	16
Fluconazole	Fluconazole	60	24
Alendronate Sodium	Alendronate Sodium	58	17
Hydrochlorothiazide	Hydrochlorothiazide	58	16
Atenolol	Atenolol	56	18
Diclofenac Sodium	Diclofenac Sodium	56	18
Methylprednisolone	Methylprednisolone	56	30
Simvastatin	Simvastatin	55	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	54	35
Dropsafe Prep Pads	Alcohol Antiseptic Pads	54	14
Clonazepam	Clonazepam	53	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	12
Meclizine Hcl	Meclizine Hcl	51	19
Synthroid	Levothyroxine Sodium	51	suppressed
Donepezil Hcl	Donepezil Hcl	49	11
Esomeprazole Magnesium	Esomeprazole Magnesium	49	12
Lactulose	Lactulose	47	12
Metoprolol Tartrate	Metoprolol Tartrate	47	13
Clindamycin Hcl	Clindamycin Hcl	46	35
Clonidine Hcl	Clonidine Hcl	46	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	23
Promethazine Hcl	Promethazine Hcl	46	12
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	44	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Lovastatin	Lovastatin	41	13
Metformin Hcl Er	Metformin Hcl	41	16
Dicyclomine Hcl	Dicyclomine Hcl	40	suppressed
Linzess	Linaclotide	40	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	39	suppressed
Levofloxacin	Levofloxacin	38	27
Farxiga	Dapagliflozin Propanediol	37	suppressed
Pregabalin	Pregabalin	37	suppressed
Ibu	Ibuprofen	36	suppressed
Bupropion Hcl Sr	Bupropion Hcl	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Doxepin Hcl	Doxepin Hcl	33	suppressed
Hydrocortisone	Hydrocortisone	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	17
Buspirone Hcl	Buspirone Hcl	28	suppressed
Cephalexin	Cephalexin	28	20
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	26	19
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	23
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Nystatin	Nystatin	25	19
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	22	suppressed
Cefuroxime	Cefuroxime Axetil	22	18
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Diazepam	Diazepam	21	suppressed
Nabumetone	Nabumetone	21	suppressed
Lorazepam	Lorazepam	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	15
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Amoxicillin	Amoxicillin	18	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Temazepam	Temazepam	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Finasteride	Finasteride	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Oxazepam	Oxazepam	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Trandolapril	Trandolapril	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Aliskiren	Aliskiren Hemifumarate	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Silodosin	Silodosin	13	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Glipizide	Glipizide	12	suppressed
Loxapine	Loxapine Succinate	12	suppressed
Ramipril	Ramipril	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error